$66.53 -0.06 (%) Eli Lilly & Co - NYSE

Sep. 19, 2014 | 04:00 PM

Partner Headlines

  1. Lipocine Inc Halted: Feds Eye Safety, Efficacy Of Testosterone

    Benzinga | Sep. 17, 2014 | 11:45AM EST
  2. Drug giants target Alzheimer's

    IBD | Sep. 16, 2014 | 18:49PM EST
  3. What Is A High Risk Market?

    Benzinga | Sep. 8, 2014 | 09:39AM EST
  4. Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures

    GuruFocus | Aug. 28, 2014 | 12:21PM EST
  5. Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend

    Benzinga | Aug. 27, 2014 | 17:17PM EST
  6. Deutsche Bank: Eli Lilly At 'Critical Stage' In Its Journey

    Benzinga | Aug. 27, 2014 | 12:55PM EST
  7. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold

    Benzinga | Aug. 27, 2014 | 12:32PM EST
  8. New Type 2 Diabetes Treatment Jardiance Tablets For Adults Now Available In U.S. Pharmacies

    Benzinga | Aug. 26, 2014 | 09:04AM EST
  9. UPDATE: Tigress Initiates Coverage On Eli Lilly

    Benzinga | Aug. 1, 2014 | 15:48PM EST
  10. Dow Suffers 300 Point Drop; S&P 500 And Nasdaq Also Tumble

    Benzinga | Jul. 31, 2014 | 16:49PM EST
  11. Stocks Lower As Earnings Season Takes Back Seat To Geopolitical Uncertainties

    Benzinga | Jul. 29, 2014 | 16:37PM EST
  12. Thursday Morning Earnings Reports

    Benzinga | Jul. 24, 2014 | 12:14PM EST
  13. Earnings Scheduled For July 24, 2014

    Benzinga | Jul. 24, 2014 | 05:31AM EST
  14. New Study Shows Beta-Amyloid Imaging Is Associated With Altered Diagnosis And Management Of Alzheimer's Disease

    Benzinga | Jul. 16, 2014 | 08:18AM EST
  15. Lilly And Immunocore Enter Immunotherapy Agreement To Co-Discover And Co-Develop Novel Cancer Therapies

    Benzinga | Jul. 16, 2014 | 07:05AM EST
  16. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 15, 2014 | 08:14AM EST
  17. US Stock Futures Mostly Higher Ahead Of Goldman Sachs Earnings

    Benzinga | Jul. 15, 2014 | 07:34AM EST
  18. Barclays Downgrades Pharmaceutical Sector

    Benzinga | Jul. 2, 2014 | 15:31PM EST
  19. UPDATE: Barclays Upgrades Eli Lilly Despite Sector Downgrade

    Benzinga | Jul. 2, 2014 | 09:40AM EST
  20. Benzinga's Top Upgrades

    Benzinga | Jul. 2, 2014 | 08:24AM EST
  21. Eli Lilly is on the Right Track

    GuruFocus | Jun. 25, 2014 | 11:02AM EST
  22. Celgene Sees Better Results For Psoriatic Arthritis

    IBD | Jun. 20, 2014 | 18:12PM EST
  23. Eli Lilly Bets Big on Diabetes, Cancer Drugs

    FoxBusiness | Jun. 20, 2014 | 12:31PM EST
  24. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD | Jun. 13, 2014 | 17:29PM EST
  25. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga | Jun. 4, 2014 | 13:58PM EST
  26. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted Therapy

    Benzinga | Jun. 4, 2014 | 10:32AM EST
  27. John Paulson's 4 Stocks Trading for Less Than He Paid for Them

    GuruFocus | Jun. 2, 2014 | 18:35PM EST
  28. Lilly Says Abemaciclib in Phase 1 Study Demonstrated Single-Agent Activity

    Benzinga | May. 14, 2014 | 17:05PM EST
  29. Eli Lilly insulin trial succeeds

    IBD | May. 12, 2014 | 18:42PM EST
  30. Cross-Border Megamergers Drive Global Takeover Boom

    IBD | May. 12, 2014 | 17:01PM EST
  31. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga | May. 12, 2014 | 16:27PM EST
  32. Eli Lilly's Basal Insulin Outperforms Lantus In Trial

    IBD | May. 12, 2014 | 12:04PM EST
  33. UPDATE: Eli Lilly Announces Peglispro Shows Superiority Compared to Insulin Glargine in HBA1C

    Benzinga | May. 12, 2014 | 09:05AM EST
  34. Can Pfizer Make Up Its Loss?

    GuruFocus | May. 9, 2014 | 19:24PM EST
  35. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD | May. 6, 2014 | 18:16PM EST
  36. Bayer Buys Merck Consumer Care Unit

    FoxBusiness | May. 6, 2014 | 06:22AM EST
  37. Will Pfizer's Q1 2014 Earnings Beat the Street on May 5, 2014?

    GuruFocus | May. 5, 2014 | 13:21PM EST
  38. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness | May. 2, 2014 | 06:14AM EST
  39. Novo Nordisk Struggles In U.S. Market; Q1 Sales Miss

    IBD | May. 1, 2014 | 17:01PM EST
  40. Novo Nordisk Q1 Revenue Misses; Guidance Lowered

    IBD | May. 1, 2014 | 11:48AM EST
  41. Vanguard Health Care Fund's Top Quarterly Holdings

    GuruFocus | Apr. 30, 2014 | 19:19PM EST
  42. Actavis Earns Over-The-Top Q1

    IBD | Apr. 30, 2014 | 18:50PM EST
  43. Actavis Beats Q1 Views, Looks To Supersized Future

    IBD | Apr. 30, 2014 | 17:28PM EST
  44. Actavis Q1 Earnings Beat On Generic Cymbalta Surprise

    IBD | Apr. 30, 2014 | 11:10AM EST
  45. China Rule Change Further Opens Yuan To World Markets

    IBD | Apr. 28, 2014 | 18:31PM EST
  46. These Three Pharmaceutical Companies Shake The Market With Their Deal

    GuruFocus | Apr. 27, 2014 | 23:06PM EST
  47. Drugmakers' Q1 was anemic

    IBD | Apr. 24, 2014 | 18:36PM EST
  48. Eli Lilly Jr. Made His Firm A Pharmaceutical Power

    IBD | Apr. 24, 2014 | 13:30PM EST
  49. Earnings Scheduled For April 24, 2014

    Benzinga | Apr. 24, 2014 | 05:33AM EST
  50. Big Pharmas Swap Specialties

    IBD | Apr. 22, 2014 | 18:41PM EST
Trading Center